Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Update on the Safety and Efficacy of JAK Inhibitor Therapeutics for the Treatment of Atopic Dermatitis

Program Overview

This CME program will provide clinicians with an update regarding the safety and efficacy of JAK inhibitor therapeutics for the treatment of atopic dermatitis. The expert faculty, led by Dr. Lawrence F. Eichenfield, will first outline current clinical trial data for JAK-1 inhibitor therapeutics in atopic dermatitis (AD), encompassing topics such as difficulties living with AD and the ...
View Course
The Impact of the COVID Pandemic on Continuity of Care and Adherence to DAPT Among Patients with CAD/ACS/PCI

Program Overview

Areas of North America and Western Europe have struggled with repeated waves and emerging variants of SARS CoV-2 infection. Even as some countries and regions strive to return to pre-pandemic behavior, the COVID-19 pandemic continues to exert many deleterious effects on the delivery of continuing healthcare for many vulnerable populations. Those affected include patients who would be expected ...
View Course
Advances in Biomarkers and Anti BCMA Therapeutics to Improve Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Program Overview

This CME/CE program will highlight recent advances in the treatment and management of patients with relapsed/refractory multiple myeloma (RRMM). The expert faculty, led by C. Ola Landgren, MD, will first discuss best practices for integrating BCMA-targeted therapy into treatment plans for patients with RRMM. Following, emerging therapies in relapsed and remitting multiple myeloma will be reviewed, analyzing both ...
View Course
Practical Applications of S1P Therapeutics for the Treatment of Relapsing Forms of Multiple Sclerosis

Program Overview

This CME/CE program is derived from content presented at the ACTRIMS Forum 2022. The educational activity, chaired by Fred D. Lublin, MD, will analyze best practices for incorporating sphingosine 1 phosphate (S1P) therapeutics in treatment plans for patients with multiple sclerosis (MS). The expert faculty will first outline the pathophysiology and specific science of all S1P receptor modulators ...
View Course
Optimal Guideline Directed Medical Therapy for Heart Failure

Program Overview

This CME/CE program will highlight optimal guideline directed medical therapy for patients with heart failure (HF). The expert faculty will first review current ACC/AHA and ESC recommendations for directed medical therapy to treat patients with heart failure with reduced ejection fraction (HFrEF). Following, the faculty will analyze clinical trial data for SGLT2is, vericiguat, and omecamtiv mecarbil therapeutics. Next, ...
View Course
Therapeutic Advances in the Management of Patients with Gastrointestinal Cancer

Program Overview

This CME post-conference review and analysis will highlight therapeutic advances in the management of patients with gastrointestinal cancer, including data presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2022. The expert faculty will analyze the latest therapeutic advances for the treatment and management of gastrointestinal (GI) cancer as presented at ASCO GI 2022. They ...
View Course

Upcoming Events

Georgia Neurological Society Annual Meeting

March 17th – 18th, 2023

Academy of Managed Care Pharmacy 2023 Meeting

March 21st – 24th, 2023

American Association for Cancer Research Annual Meeting 2023

April 14th – 19th, 2023

European Association of Cardiovascular Imaging 2023 Meeting

May 10th – 12th, 2023

Leave a Reply

Your email address will not be published. Required fields are marked *